Nexstim Oyj (FRA:5NX)
€ 9.78 +0.56 (+6.07%) Market Cap: 78.14 Mil Enterprise Value: 75.97 Mil PE Ratio: 0 PB Ratio: 9.25 GF Score: 69/100

Full Year 2024 Nexstim Oyj Earnings Call Transcript

Feb 27, 2025 / 01:00 PM GMT
Release Date Price: €9.44 (+3.74%)

Key Points

Positve
  • Nexstim Oyj (FRA:5NX) reported a 21% growth in total net sales for the full year 2024, reaching €8.7 million.
  • The company achieved a positive EBITDA for the first time, excluding non-recurring license income, indicating operational profitability.
  • The partnership with Brainlab is expected to significantly increase system and service sales volume, leveraging Brainlab's extensive customer base and market presence.
  • The therapy business saw a substantial growth of 42% in 2024, driven by the successful launch of the NBS 6 therapy system.
  • Nexstim Oyj (FRA:5NX) has a strong cash flow from operating activities, which was positive at €1.9 million, reflecting improved financial stability.
Negative
  • Operating expenses increased by approximately 8%, with notable rises in sales, marketing, and administrative costs.
  • The company reported an operating loss of €0.5 million, despite improvements from the previous year.
  • There is a high accounts receivable balance of €3.9 million due to strong system sales in December, which could impact cash flow if not managed properly.
  • The equity ratio remained relatively unchanged at around 31%, indicating limited improvement in financial leverage.
  • The company faces regulatory challenges in launching the NBS 6 diagnostic system in key markets, with no specific timeline provided for approvals.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

NXTMH.HE - Nexstim Oyj
Full Year 2024 Nexstim Oyj Earnings Call
Feb 27, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
My name is Mikko Carvinin. I'm the CEO of Nexim.

And I will be presenting today our last year 24 financials, both, second half of 24 and full year 24. I'm also going to be assisted by our Chief Financial Officer Jonaswalatti, who will be going through some numbers, mainly the full year 24 figures.

I'll start off with a few slides.

First, we've been doing some updating of our strategy during last year 24 and, our new strategy period has begun this year 25 and will be ongoing until year 28.

Here's a picture from, as a result of our strategy work that shows the main elements of our strategy, and I will briefly go through some of these, to assist your understanding of our future.

In on the top of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot